Latest filing published 29 May 2026 for TuHURA Biosciences, Inc./NV.
Filings by James A. Bianco span 2 companies, the busiest being CTI Biopharma Corp and TuHURA Biosciences, Inc./NV. We count 10 filings; the first trade dates from 29 January 2016 and the latest from 28 May 2026.
The open-market record consists of 8 sales worth €225k, with no purchase. Besides market trades, the filings include 1 share grant.
The latest filing, published on 29 May 2026, reports a transaction in TuHURA Biosciences, Inc./NV. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations